<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.3" xml:lang="EN" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Chem Biol</journal-id><journal-id journal-id-type="iso-abbrev">ACS Chem Biol</journal-id><journal-id journal-id-type="publisher-id">cb</journal-id><journal-id journal-id-type="coden">acbcct</journal-id><journal-title-group><journal-title>ACS Chemical Biology</journal-title></journal-title-group><issn pub-type="ppub">1554-8929</issn><issn pub-type="epub">1554-8937</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10127202</article-id><article-id pub-id-type="pmid">37014749</article-id><article-id pub-id-type="doi">10.1021/acschembio.3c00063</article-id><article-categories><subj-group><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Genome-Guided
Discovery of the Myxobacterial Thiolactone-Containing
Sorangibactins</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Gao</surname><given-names>Yunsheng</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref><xref rid="notes-1" ref-type="notes">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Walt</surname><given-names>Christine</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref><xref rid="notes-1" ref-type="notes">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Bader</surname><given-names>Chantal D.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath4"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1042-5665</contrib-id><name><surname>M&#x000fc;ller</surname><given-names>Rolf</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department
of Microbial Natural Products, <institution>Helmholtz-Institute
for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for
Infection Research (HZI) and Department of Pharmacy at Saarland University</institution>, Campus E8.1, 66123 Saarbr&#x000fc;cken, <country>Germany</country></aff><aff id="aff2"><label>&#x02021;</label><institution>Helmholtz
International Lab for Anti-Infectives</institution>, Campus E8.1, 66123 Saarbr&#x000fc;cken, <country>Germany</country></aff><aff id="aff3"><label>&#x000a7;</label>German
Center for Infection Research (DZIF), <institution>Partner
Site Hannover-Braunschweig</institution>, 38124 Braunschweig, <country>Germany</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>rolf.mueller@helmholtz-hips.de</email>.</corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>04</month><year>2023</year></pub-date><pub-date pub-type="collection"><day>21</day><month>04</month><year>2023</year></pub-date><volume>18</volume><issue>4</issue><fpage>924</fpage><lpage>932</lpage><history><date date-type="received"><day>30</day><month>01</month><year>2023</year></date><date date-type="accepted"><day>24</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 American Chemical Society</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb3c00063_0006" id="ab-tgr1"/></p><p>In
this study, an unprecedented myxobacterial siderophore
termed
sorangibactin was discovered by heterologous expression of a coelibactin-like
nonribosomal peptide synthetase (NRPS) gene cluster from the <italic>Sorangiineae</italic> strain MSr11367 in the host <italic>Myxococcus xanthus</italic> DK1622. De novo structure elucidation
uncovered a linear polycyclic structure consisting of an N-terminal
phenol group, an oxazole, tandem <italic>N</italic>-methyl-thiazolidines,
and an unusual C-terminal &#x003b3;-thiolactone moiety. Except for the
unprecedented oxazoline dehydrogenation to form an oxazole, which
we show to be catalyzed by a cytochrome P450-dependent enzyme, other
tailoring steps were found necessary for efficient downstream processing.
The unusual thioesterase (TE) domain is proposed to select homocysteine
or methionine for offloading involving an intramolecular &#x003b3;-thiolactone
formation. Its active site comprises a rare cysteine, which was found
essential for product formation by point mutation to alanine or serine,
which both abolished its activity. This unusual release mechanism
and the resulting rare thiolactone structure can serve as a starting
point for detailed biochemical investigations.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>Deutsches Zentrum f&#x000c3;&#x000bc;r Infektionsforschung</institution><institution-id institution-id-type="doi">10.13039/100009139</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>China Scholarship Council</institution><institution-id institution-id-type="doi">10.13039/501100004543</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Deutsche Forschungsgemeinschaft</institution><institution-id institution-id-type="doi">10.13039/501100001659</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>cb3c00063</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>cb3c00063</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>Myxobacteria are Gram-negative
&#x003b4;-proteobacteria featuring
unique morphological characteristics, complex life cycles, large genomes,
and a particularly huge biosynthetic potential for secondary metabolite
production.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Hundreds of structurally interesting
scaffolds and bioactive compounds from myxobacteria were discovered
over the past decades.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Despite this rich
collection of characterized secondary metabolites, genome sequencing
as well as biosynthetic gene cluster (BGC) annotation have revealed
that the majority of the myxobacterial biosynthetic potential is still
untapped.<sup><xref ref-type="bibr" rid="ref3">3</xref>&#x02212;<xref ref-type="bibr" rid="ref5">5</xref></sup> Thus, a &#x0201c;gene to compound&#x0201d; strategy
can shed light on assigning secondary metabolites to their BGCs and
finding unprecedented structures. As myxobacteria, especially the <italic>Sorangiineae</italic> suborder, are usually slow growing and barely
tractable for genetic manipulation, heterologous expression is particularly
promising to explore them, as it facilitates not only genome mining
for natural product discovery but also biosynthetic pathway engineering
and detailed biosynthesis studies.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> One
prolific starting point for the examination of cryptic BGCs are so-called
broad cosmid libraries,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> which can comprise
the entire genome of a selected bacterial strain in the form of plasmid
DNA and facilitate high-throughput heterologous expression.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> This approach also enables the unambiguous correlation
of BGCs with their products.</p><p>One interesting structural class
of natural products are bacterial
siderophores, which are small-molecular-weight Fe(III)-specific ligands
that scavenge iron from their environment and enable uptake into the
cell through outer-membrane transporters.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> Siderophores from myxobacteria belong to two main categories, namely,
the catecholate-type such as the myxochelins<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> and hyalachelins<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> and the citrate-hydroxamate-type
such as the nannochelins.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> On the contrary,
over 500 congeners of diverse siderophore families have been described
from actinobacteria.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> One particularly
puzzling actinobacterial siderophore is coelibactin, the existence
of which has only been proposed based on the presence of the respective
BGC and for which only a hypothetical chemical structure is found
in the literature. Comprehensive bioinformatics analysis of the respective
BGC found in the model species <italic>Streptomyces coelicolor</italic> A3(2)<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> enabled a prediction of the core
structure based on the predicted sequence of the nonribosomal peptide
synthetase (NRPS) gene cluster, yet isolation of coelibactin or derivatives
thereof failed for unknown reasons.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup></p><p>In this study, we report the discovery of a novel myxobacterial
secondary metabolite with siderophore-like behavior termed sorangibactin
from the <italic>Sorangiineae</italic> strain MSr11367 by heterologous
expression of a promoter-engineered NRPS gene cluster, which resembles
the coelibactin BGC. This coelibactin-like NRPS gene cluster was prioritized
due to the following reasons: (1) its bioinformatically predicted
structure resembles coelibactin from <italic>Streptomyces coelicolor</italic> A3(2),<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> which raises hope to contribute
to solving the puzzle of the coelibactins, (2) its regular operon
organization, which is suitable for promoter engineering, and (3)
multiple tailoring genes surrounding the core NRPS part, which indicates
auxiliary modifications before or after chain release and may endow
the final product with structural novelty and diversity.</p></sec><sec id="sec2"><label>2</label><title>Results and Discussion</title><sec id="sec2.1"><label>2.1</label><title>Heterologous Expression
of a Coelibactin-like
NRPS Gene Cluster</title><p>According to the antiSMASH prediction,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> the myxobacterial <italic>Sorangiineae</italic> strain MSr11367 exhibits a great biosynthetic potential of 62 biosynthetic
gene clusters and thus was prioritized for natural product discovery.
The strain was already explored using an OSMAC (one strain many compounds)
metabolomics approach in our laboratory, but even altered cultivation
conditions did not reflect its full biosynthetic potential making
this strain particularly interesting for genome-based discovery. Despite
several efforts, MSr11367 proved to be intractable for in situ genetic
manipulation. Therefore, a genomic DNA library in the form of cosmids
was generated for systematic screening of biosynthetic gene clusters
by heterologous expression in the genetically amenable host <italic>Myxococcus xanthus</italic> DK1622.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Among the 62 BGCs encoded in the strain&#x02019;s genome, we prioritized
a coelibactin-like NRPS gene cluster that showed widespread occurrence
of homologous BGCs in <italic>Sorangium cellulosum</italic>, <italic>Streptomyces</italic>, and <italic>Pseudomonas</italic> strains (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A), presumably indicating a conserved function of the correlating
secondary metabolites during evolution. The MSr11367 coelibactin-like
gene cluster (sorangibactin BGC) has been deposited in the GenBank
under the accession number OQ368584. The respective annotation of
the gene cluster is provided in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Supporting Table S1</ext-link>.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Characterization of the coelibactin-like NRPS gene cluster from
the <italic>Sorangiineae</italic> strain MSr11367. (A) Proposed structure
of coelibactin from <italic>S. coelicolor</italic> A3(2)
and clinker analysis of selected coelibactin BGC homologues from different
bacterial species. The BGC from MSr11367 with gene names is shown
at the top and has been characterized in this study. Genes with a
&#x0003e;30% sequence identity are assigned a unique color and linked.
(B)
Significant difference between the heterologous expression data set
(DK1622::km-Pvan-srb) encircled in red and the wild-type host data
set (DK1622) encircled in blue shown by a PCA score plot. (C) Molecular
features that contribute to this difference shown by a PCA loading
plot. (D) Molecular features that are only found in the heterologous
expression data set. (E) HPLC-MS chromatogram of sorangibactin A production
by DK1622::km-Pvan-srb (red) and MSr11367 (orange).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb3c00063_0002" id="gr1" position="float"/></fig><p>The unmodified gene cluster was cloned from the
cosmid library
of the <italic>Sorangiineae</italic> strain MSr11367 and transferred
to the host <italic>M. xanthus</italic> DK1622 for expression;
however, no heterologous product was detected. Thus, a <italic>km-vanR-Pvan</italic> cassette was inserted between the two main operons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S1</ext-link>), after which the first operon consisting
of transporter genes shares a strong constitutive promoter with the
kanamycin resistance gene and the second operon consisting of biosynthesis
genes is under the control of a vanillate-inducible Pvan promoter.
Principal component analysis (PCA) of high-performance liquid chromatography&#x02013;high-resolution
mass spectrometry (HPLC-HRMS) datasets revealed several molecular
features exclusively present in <italic>M. xanthus</italic> DK1622 mutants containing the promoter-engineered gene cluster and
absent in the <italic>M. xanthus</italic> DK1622 wild-type
host (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B&#x02013;D).
The major component (termed sorangibactin A) could also be found in <italic>Sorangiineae</italic> strain MSr11367 extracts in equal concentrations
when cultivated under iron-deficient conditions, indicating it as
the final product of the respective BGC (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>E). Isolation for structure elucidation was
performed utilizing the heterologous host, as besides its less complex
metabolome that was beneficial for the purification process, it also
shows faster growth rates reducing possible contamination issues during
cultivation as observed for the strain MSr11367.</p></sec><sec id="sec2.2"><label>2.2</label><title>Characterization of Sorangibactins</title><p>HPLC-HRMS measurements
exhibit an [M + H]<sup>+</sup> peak for the
mixture of sorangibactins A1 and A2 at <italic>m</italic>/<italic>z</italic> 507.1190 matching the molecular formula C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>4</sub>S<sub>3</sub><sup>+</sup> (<italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> 507.1189, &#x00394;0.2 ppm) featuring 12 double-bond equivalents (DBEs).
Combined one-dimensional (1D) and two-dimensional (2D) NMR spectra
uncovered a system comprising four heterocycles and one phenol, starting
from the N-terminus with a phenol substituted by an oxazole group
in the <italic>ortho</italic>-position, which is further connected
to two consecutive <italic>N</italic>-methylated thiazolidines linked
via an amide bond to a cyclic &#x003b3;-thiolactone as the C-terminal
end (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). The
assignment of the oxazole moiety and the unusual C-terminus was underpinned
by <sup>1</sup>H-<sup>15</sup>N HMBC experiments (see the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">SI</ext-link>) as well as the comparison of the chemical
shifts for the homocysteine thiolactone part to already published
NPs like thiolactomide.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> The two signal
sets for sorangibactins A1 and A2 were identical besides the signal
area of the isomerization of the C-terminal homocysteine thiolactone
upon purification. The corresponding methine signal for atom 4 of
sorangibactin A1 is located at &#x003b4;(<sup>1</sup>H) = 4.09 ppm and
of A2 at &#x003b4;(<sup>1</sup>H) = 4.16 ppm, whereas the adjoining
diastereotopic methylene group (atom 3) of sorangibactin A1 shows
a signal at &#x003b4;(<sup>1</sup>H) = 2.10/1.92 ppm and A2 features
a methylene group without any diastereotopic effect at &#x003b4;(<sup>1</sup>H) = 2.04 ppm. It is worth noting that, in the thiolactone
part, the HMBC correlation between the methylene group (atom 2) at
&#x003b4;(<sup>1</sup>H) = 3.01 ppm and the carbonyl group (atom 1)
at &#x003b4;(<sup>13</sup>C) = 179.5 ppm could not be identified. Nevertheless,
the predicted thiolactone ring is underpinned by the COSY and HMBC
correlations between atoms 2 and 3 as well as atom 4 by the HMBC correlations
from atom 4 and atom 3 to atom 1 as well as the predicted 12 DBEs
in agreement with the predicted sum formula.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Chemical structures of
sorangibactins A1 and A2 (<bold>1</bold> and <bold>2</bold>) and B
(<bold>3</bold>) with atom numbering and
main COSY (bold) and HMBC (arrows) correlations.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb3c00063_0003" id="gr2" position="float"/></fig><p>Several structure parts of sorangibactin show similarities
to well-described
siderophores; however, it features some uncommon modifications. The <italic>ortho</italic>-phenol moiety originating from salicylic acid incorporation
is also present in yersiniabactin produced by <italic>Yersinia
pestis</italic>(<xref ref-type="bibr" rid="ref19">19</xref>) and predicted
for coelibactin from <italic>Streptomyces coelicolor</italic>.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> Furthermore, yersiniabactin features
one thiazolidine moiety and two dihydrothiazoles, whereby the thiazolidine
in contrast to sorangibactin is not <italic>N</italic>-methylated
and no dihydrothiazoles are present in sorangibactin. The oxazole
moiety in sorangibactin is different from the methylated dihydrooxazole
predicted for coelibactin. Finally, the main structural difference
of sorangibactin to published siderophores is clearly the uncommon
homocysteine thiolactone at the C-terminus, reflecting the unprecedented
structure of sorangibactin. This structural moiety impeded the purification
procedure and also sheds light on possible obstacles that might have
hindered structure elucidation of coelibactin: sorangibactins A1 and
A2 undergo hydrolysis during the standard purification setup with
formic acid as a modifier, resulting in the C-terminally ring-opened
sorangibactin B. The &#x003b1;-proton of the acid labile homocysteine
thiolactone tends to isomerize even when using the adapted purification
workflow leading to a mixture of the two isomers sorangibactins A1
and A2 (see the <xref rid="sec4" ref-type="other">Methods</xref> section). Even though
we could not separate these two isomers, the corresponding NMR data
set of the mixture enabled the structural assignment of both of them.</p><p>For the stereochemical assignment of sorangibactins A1 and A2,
only Marfey&#x02019;s derivatization assay was applicable since this
molecule is a peptide without any functionalities accessible for Mosher
esterification and due to its instabilities not attainable for crystallization
experiments as exemplarily performed to solve the stereochemistry
of the related siderophore yersiniabactin.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> Marfey&#x02019;s analysis however could also only provide limited
information for three main reasons: (1) the hydrolysis of thiazolidines
is known to lead to the oxidation state of an aldehyde instead of
the free acid, which is instable and degrades,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> (2) the stereocenters at positions 9 and 15 originate from
the former carboxyl function of the cysteine before cyclization to
the thiazolidine group and thus would lose stereo information again
upon hydrolysis, and (3) the mixture of sorangibactins A1 and A2 contains
both <italic>R</italic>- and <italic>S</italic>-configurations of
the &#x003b1;-proton of the C-terminal homocysteine thiolactone, which
cannot be separated. Consequently, only positions 7 and 12 could reasonably
be accessible by Marfey&#x02019;s analysis, but they were found to
isomerize during hydrolysis. HPLC-HRMS analysis displayed a mixture
of four enantiomers with a mass of <italic>m</italic>/<italic>z</italic> 430.14 &#x000b1; 0.02 corresponding to FDLA-derivatized <italic>N</italic>-methyl cysteine and homocysteine (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S2</ext-link>). Hence, we can solely present the flat structure with a bioinformatic
prediction of all <italic>S</italic>-configurations due to the absence
of an epimerase in the respective modules.</p><p>We also obtained
a second congener of the sorangibactin family
through provoking hydrolysis of the rather labile thioester yielding
the ring-opened product sorangibactin B (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). HPLC-HRMS experiments show an [M + H]<sup>+</sup> peak for sorangibactin B at <italic>m</italic>/<italic>z</italic> 525.1298 with a predicted molecular formula C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>5</sub>S<sub>3</sub><sup>+</sup> (<italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> 525.1295,
&#x00394;0.6 ppm) featuring 11 double-bond equivalents (DBEs). Noteworthily,
more than five isomers of sorangibactin B are present in fractions
that underwent the hydrolyzing isolation conditions using formic acid
during purification. The presumably isomerizing stereocenters are
most likely the ones belonging to the homocysteine and the two thiazolidine
parts exhibiting five stereocenters. Thus, the following structure
elucidation belongs to the most abundant isomer unveiling the most
intensive NMR correlations. In contrast to sorangibactins A1 and A2,
the cyclic homocysteine thiolactone is opened, which shows an impact
on the corresponding shifts due to the more shielded free carboxylic
acid (atom 1) with a shift at &#x003b4;(<sup>13</sup>C) = 176.6 ppm
compared to the former thioester function. The HMBC spectrum exhibits
two correlations to the free carboxyl group (atom 1) from methylene
groups (atoms 2 and 3) at &#x003b4;(<sup>1</sup>H) = 2.27 and 1.59 ppm.
The more downfield-shifted signal can be explained by the close neighborhood
to the thiol function. Corresponding COSY correlations from the more
shielded methylene group (atom 3) to the homocysteine &#x003b1;-proton
(atom 4) at &#x003b4;(<sup>1</sup>H) = 4.68 ppm can be observed. Furthermore,
HMBC correlations evince from atom 4 as well as the methine group
of the adjacent thiazolidine ring (atom 7) at &#x003b4;(<sup>1</sup>H) = 3.57 ppm to the connective amide group (atom 6) at &#x003b4;(<sup>13</sup>C) = 173.0 ppm. Comparing the remaining data set to sorangibactins
A1 and A2, the signals corresponding to the N-terminal part from atom
8 to 26 are similar with &#x02264;0.1 ppm deviation for <sup>1</sup>H and &#x02264;2.1 ppm for <sup>13</sup>C shifts.</p><p>MS<sup>2</sup> spectral analysis was performed to obtain additional
evidence supporting the proposed structures for sorangibactins A1,
A2, and B. Just as for the structurally related siderophores yersiniabactin,
ulbactin B, and escherichelin, characteristic fragmentation behavior
can also be observed for sorangibactins.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> The three main fragment ions of sorangibactin B are in accordance
with the respective bond cleavages in A1 and A2 (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A). Fragment ions b, c, and
d of <bold>1</bold> and <bold>2</bold> correspond to fragment ions
b, c+H<sub>2</sub>O, and d+H<sub>2</sub>O of <bold>3</bold>.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Characterization
of sorangibactins by MS<sup>2</sup> analysis and
feeding stable isotopes. (A) Proposed fragmentation pattern of <bold>1</bold> and <bold>2</bold> with abundant fragment ions a&#x02013;f
(upper chromatogram) and of <bold>3</bold> with fragment ions b, c+H<sub>2</sub>O, and d+H<sub>2</sub>O (lower chromatogram). The predicted <italic>m</italic>/<italic>z</italic> of each fragment is marked in red.
(B) Feeding salicylic acid-<italic>d</italic><sub>6</sub> (yellow), <sc>l</sc>-serine-<sup>13</sup>C<sub>3</sub>,<sup>15</sup>N (green), <sc>l</sc>-cysteine-<sup>13</sup>C<sub>3</sub>,<sup>15</sup>N (orange),
and <sc>l</sc>-methionine-<sup>13</sup>C<sub>5</sub>,<sup>15</sup>N (blue).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb3c00063_0004" id="gr3" position="float"/></fig><p>The N-terminal phenol group derived
from salicylic
acid is further
supported by feeding 2-hydroxybenzoic acid-<italic>d</italic><sub>6</sub>, resulting in a +4 mass shift of the respective fragment
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B). Feeding <sc>l</sc>-serine-<sup>13</sup>C<sub>3</sub>,<sup>15</sup>N and <sc>l</sc>-cysteine-<sup>13</sup>C<sub>3</sub>,<sup>15</sup>N resulted in the
+4 and +8 mass shift, respectively, which indicates the NRPS to incorporate
one serine and two cysteines and is consistent with the proposed sorangibactin
structure containing one oxazole and two thiazolidine substructures.
Interestingly, feeding <sc>l</sc>-methionine-<sup>13</sup>C<sub>5</sub>,<sup>15</sup>N not only showed a +1 mass shift indicating a methyl
transfer but also a +5, which indicated the incorporated homocysteine
originating from methionine at the C-terminus, which is additionally
supported by MS<sup>2</sup> analysis. This is consistent with the
C-terminal &#x003b3;-thiolactone structure.</p><p>Sorangibactins A1
and A2 showed no obvious bioactivity against
our test panel of bacterial and fungal pathogens and selected cell
lines (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Table S2</ext-link>). However, siderophore-like
behavior was observed during UHR-TOF measurements even before the
purification of sorangibactin. Besides the double charged species
at <italic>m</italic>/<italic>z</italic> 254.0632 and the [M + H]<sup>+</sup> signal at <italic>m</italic>/<italic>z</italic> 507.1190,
the MS spectrum of sorangibactins A1 and A2 exhibits a peak at <italic>m</italic>/<italic>z</italic> 560.0307. With a mass distance of <italic>m</italic>/<italic>z</italic> 52.9117 to the [M + H]<sup>+</sup> peak,
it equals [M &#x02013; 2H + Fe<sup>3+</sup>]<sup>+</sup> with the predicted
sum formula of C<sub>22</sub>H<sub>24</sub>FeN<sub>4</sub>O<sub>4</sub>S<sub>3</sub><sup>+</sup> (<italic>m</italic>/<italic>z</italic> calcd
for [M &#x02013; 2H + Fe<sup>3+</sup>]<sup>+</sup> 560.0304, &#x00394;0.5
ppm) and shows a characteristic M-2 iron isotope peak (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S3</ext-link>).<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> Additional
evidence about sorangibactin being a siderophore is obtained by cultivation
of MSr11367 under iron-deficient conditions using RGAE2 medium and
iron-rich conditions by supplementing 1 mM FeCl<sub>3</sub>. As a
result, iron limitation during cultivation induced the production
of sorangibactin, whereas external addition of iron suppressed the
production (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S4</ext-link>). This is a well-established
indicator for siderophore features of molecules.<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup> Apart from that, possibilities to determine the exact affinity to
iron in terms of binding properties is commonly conducted via competition
experiments with a strong binder like EDTA.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> However, this approach was not possible for the sorangibactins due
to their instability and isomerization issues during the purification
process.</p></sec><sec id="sec2.3"><label>2.3</label><title>Proposed Biosynthesis of the Sorangibactins</title><p>The sorangibactin BGC spans approximately 32 kb of DNA sequence,
from which 17 proteins are annotated (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Table S1</ext-link>) and proposed to be involved in biosynthesis (SrbA&#x02013;SrbK),
transportation (SrbL&#x02013;SrbP), and regulation (SrbR). Besides
in silico analysis, gene deletion and point mutation by Red&#x003b1;&#x003b2;
recombineering (see the <xref rid="sec4" ref-type="other">Methods</xref> section and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S1</ext-link>) were carried out using the heterologous
expression system. Based on those experiments, we present the following
biosynthesis hypothesis of the sorangibactins.</p><p>Biosynthesis
of the sorangibactins was initiated by salicylic acid formation catalyzed
by SrbB, which shows 48.5% similarity with Irp9, a bifunctional salicylate
synthase from <italic>Yersinia enterocolitica</italic> that can convert chorismate to salicylic acid in yersiniabactin
biosynthesis.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> Deletion of <italic>srbB</italic> abolished heterologous production of sorangibactins in <italic>M. xanthus</italic> DK1622, whereas feeding salicylic acid
to the <italic>srbB</italic> knockout mutant restored the production
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S5</ext-link>). The salicylic acid was then
adenylated and loaded to the first carrier protein of SrbC by SrbK
(<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A), a stand-alone
A domain-containing protein, which is predicted to use salicylic acid
as a substrate (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Table S3</ext-link>). Deletion of <italic>srbK</italic> completely abolished the heterologous production of
sorangibactins in <italic>M. xanthus</italic> DK1622
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S6</ext-link>). SrbC and SrbD are nonribosomal
peptide synthases, which comprise seven and five domains, respectively
(<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A). Each adenylation
domain was predicted by antiSMASH to use cysteine as a substrate (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Table S3</ext-link>); however, our biosynthesis model rather
suggests the first adenylation domain in SrbC to activate serine instead,
which is further modified to form the oxazole incorporated in the
sorangibactin structure. This is consistent with the above-mentioned
result from feeding <sc>l</sc>-serine-<sup>13</sup>C<sub>3</sub>,<sup>15</sup>N (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B). The terminal thioesterase (TE) domain utilizes a cysteine as
the active-site nucleophile instead of commonly used serine (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S7</ext-link>), which is not unprecedented but rare.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> Point mutation of this cysteine to alanine or
serine (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S8</ext-link>) abolished the heterologous
production of sorangibactin A in <italic>M. xanthus</italic> DK1622 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S6</ext-link>), which indicates its
essential role. Besides, this TE domain was proposed to select homocysteine
or methionine as an intermolecular nucleophile for chain release resulting
in one more amino acid incorporation at the C-terminus, which was
confirmed by feeding <sc>l</sc>-methionine-<sup>13</sup>C<sub>5</sub>,<sup>15</sup>N (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B). Use of a free amino acid for chain release was previously
found in threonine-tagged lipopeptide biosynthesis, where the TE domain
selects the intermolecular nucleophiles threonine hydroxy or amino
groups yielding ester- and amide-linked threonine tags.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> However, the complete C-terminal homocysteine
thiolactone formation in sorangibactin biosynthesis is still unclear
and may involve other tailoring enzymes, which is still under investigation.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Characterization
of the biosynthesis of sorangibactins. (A) Gene
cluster organization and proposed biosynthetic pathway. The core biosynthetic
genes are marked in blue, the proposed additional biosynthetic genes
are marked in red, the proposed transport-related genes and regulatory
genes are marked in black and gray, respectively. CP: carrier protein
domain, HC: heterocyclization domain, A: adenylation domain, MT: methyltransferase
domain, and TE: thioesterase domain. (B) Feeding of <sc>l</sc>-Ser-2,3,3-<italic>d</italic><sub>3</sub> and incorporation into sorangibactin C, where
the proposed deuterium incorporation sites are marked in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb3c00063_0005" id="gr4" position="float"/></fig><p>Besides SrbK and SrbB&#x02013;SrbD for the core
biosynthesis, SrbE&#x02013;SrbJ
are proposed to be tailoring enzymes that work in trans. SrbE is a
putative oxidoreductase containing a saccharopine dehydrogenase NADP-binding
domain (PF03435.17) and SrbF/G are proposed to be methyltransferases.
Gene deletion of SrbE/F/G was achieved by replacing them with an ampicillin
resistance gene, followed by a Ptet promoter to drive the downstream
expression avoiding polar effects (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S1</ext-link>), which resulted in the abolishment of sorangibactin A production
and indicated their essential role for biosynthesis (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S6</ext-link>). SrbH is a cytochrome P450-dependent enzyme, sharing
remarkable similarity with the CYP105N1 from the <italic>S.
coelicolor</italic> A3(2) coelibactin biosynthetic pathway
both in sequence (36.2% identity, 51.6% similarity) and structure
(RMSD 1.895, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S9</ext-link>). Structure characterization
of CYP105N1 revealed an unexpected wide open substrate binding pocket,
which was proposed to bind the peptidyl carrier protein (PCP)-bound
substrate; however, the reaction catalyzed by CYP105N1 is still unclear.<sup><xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup> Deletion of <italic>srbH</italic> abolished sorangibactin A production
in <italic>M. xanthus</italic> DK1622, whereas another
compound, termed sorangibactin C, was found accumulated (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S6</ext-link>). Molecular ion clusters [M + H]<sup>+</sup> (<italic>m</italic>/<italic>z</italic> 509.1332) and [M +
2H]<sup>2+</sup> (<italic>m</italic>/<italic>z</italic> 255.0716)
in ESI-HRMS revealed the elemental formula C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>S<sub>3</sub> of sorangibactin C, which
shows a highly similar fragmentation pattern with sorangibactin A
and contains two more atoms of hydrogen in the first two cyclic moieties
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S10</ext-link>). Feeding <sc>l</sc>-serine-2,3,3-<italic>d</italic><sub>3</sub> revealed that these two atoms of hydrogen
originated from serine, and therefore, oxazoline instead of oxazole
is proposed for the sorangibactin C structure (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>B). SrbH therefore presumably targets the
carrier protein-bound substrate and catalyzes oxazoline dehydrogenation
to form an oxazole on the assembly line (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A). However, the accumulation of sorangibactin
C could also indicate SrbH to be a post-tailoring enzyme. SrbI shows
47.9% similarity with Irp3 from <italic>Yersinia enterocolitica</italic> (PDB: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5KVQ">5KVQ</ext-link>) and is assigned as <italic>trans</italic>-acting thiazolinyl imine
reductase, catalyzing the NADPH-dependent reduction of a CP-tethered
thiazoline ring.<sup><xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup> Deletion of <italic>srbI</italic> abolished sorangibactin A production, whereas the shunt product
sorangibactin D observed at [M + H]<sup>+</sup><italic>m</italic>/<italic>z</italic> 376.0422 (calculated C<sub>16</sub>H<sub>14</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub><sup>+</sup> 376.0420, &#x00394;0.5
ppm) was accumulated (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S11</ext-link>), which
indicates that the thiazoline reduction is necessary for downstream
processing, otherwise resulting in early hydrolytic release. SrbJ
is proposed to belong to the VOC (vicinal oxygen chelate) superfamily
that catalyzes diverse reactions.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> The
function of SrbJ in sorangibactin biosynthesis is unclear but indispensable,
as of <italic>srbJ</italic> deletion abolished sorangibactin A production
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S6</ext-link>). At this moment, we cannot
fully assign each of these biosynthesis enzymes to the structure,
as the obvious accumulation of intermediate was not observed in each
gene knockout, presumably due to the non-native intermediates stalling
the whole machinery or chemical instabilities of the resulting shunt
products.</p><p>In addition to the 10 core genes described above that
were all
experimentally confirmed to be directly involved in sorangibactin
biosynthesis, seven additional genes were found in the sorangibactin
BGC. SrbA is a proposed tailoring enzyme containing an &#x003b1;/&#x003b2;
hydrolase domain. Deletion of <italic>srbA</italic> by Red&#x003b1;&#x003b2;
recombineering (see the <xref rid="sec4" ref-type="other">Methods</xref> section and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figure S1</ext-link>) had no obvious influence on heterologous
production of sorangibactins in <italic>M. xanthus</italic> DK1622 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">Figures S5 and S6</ext-link>), which can
either be explained by a functional homologue of <italic>srbA</italic> present in the <italic>M. xanthus</italic> DK1622
chromosome or <italic>srbA</italic> being not involved in sorangibactin
biosynthesis. SrbR is an LysR family transcriptional regulator, and
SrbL&#x02013;SrbP are all transporter related. Whether or how the regulator
and these transporters are correlated to sorangibactin production,
however, was not investigated here.</p></sec></sec><sec id="sec3"><label>3</label><title>Conclusions</title><p>Genome mining and subsequent
heterologous expression enabled the
discovery of a novel myxobacterial natural product termed sorangibactin
from the myxobacterial strain MSr11367. This genomics-guided approach
highlighted the accessibility of its biosynthetic potential that was
not reflected in its metabolome in our previous studies. De novo structure
elucidation of sorangibactin revealed the presence of an unprecedented
&#x003b3;-thiolactone at the C-terminus, which may help to solve the
puzzle of the chemical structure of coelibactin based on their gene
cluster similarity via the adapted purification route reducing putative
degradation and isomerization issues as well as by providing reference
data for comparison to facilitate the structure elucidation. Both
biosynthetic pathways contain conserved cytochrome P450 enzymes, and
the coelibactin P450 CYP105N1 protein was structurally characterized;
however, their functions remained elusive before this study. Here,
we discovered the sorangibactin P450-dependent enzyme SrbH, which
is proposed to oxidize oxazoline to oxazole, representing the first
P450-mediated oxazoline dehydrogenation in NRPS biosynthesis. Furthermore,
both gene clusters involve an unusual TE domain containing a rare
active-site cysteine instead of the commonly used serine. For the
sorangibactin biosynthesis, we propose that homocysteine or methionine
is incorporated into the C-terminus by this unusual TE domain, most
probably together with other unassigned tailoring enzymes, resulting
in &#x003b3;-thiolactone moiety formation in a manner that is not yet
fully understood. Therefore, the bioinformatically predicted coelibactin
structure remains to be experimentally characterized. Future studies
could address the indispensable SrbE (saccharopine dehydrogenase NADP-binding
domain-containing protein, also present in the coelibactin biosynthetic
pathway with yet unknown function) and SrbJ (glyoxalase-like domain-containing
protein, absent in the coelibactin biosynthetic pathway but conserved
in many other BGC homologues), both of which are rare in natural product
biosynthesis and worthy for further biochemical investigations. Homologous
gene clusters are widespread not only in myxobacteria but also in <italic>Streptomyces</italic> and <italic>Pseudomonas</italic> strains, which
indicates conservative functions across bacteria and potential for
further discovery and characterization of sorangibactin analogues.</p><p>In summary, this study showcased the benefit of heterologous expression
with subsequent gene cluster engineering for the discovery and biosynthesis
investigations of myxobacterial natural products. Accessibility of
a cosmid library herein will allow further high-throughput screening
of cryptic myxobacteria BGCs by heterologous expression and facilitate
characterization of their yet untapped biosynthetic potential.</p></sec><sec id="sec4"><label>4</label><title>Methods</title><sec id="sec4.1"><label>4.1</label><title>Isolation of Sorangibactins A1, A2, and B</title><p>The heterologous
producer strain <italic>M. xanthus</italic> DK1622 mutant
containing the promoter-engineered gene cluster was
used for large-scale fermentation (see the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">SI</ext-link>). The myxobacterial extract in methanol was partitioned three times
with hexane, dried, and redissolved in water to be partitioned three
times with first ethyl acetate and later chloroform. Subsequently,
the obtained chloroform phase was redissolved in methanol and fractionated
with an Isolera Spektra One (Biotage) system. Respective fractions
containing sorangibactins A1 and A2 were further purified using a
Dionex Ultimate 3000 SL system comprising a SWPS 3000 SL autosampler,
P680 pump, TCC100 column oven heated to 45 &#x000b0;C, PDA100 UV-detector
at 220 nm, and an AFL 3000 fraction collector. In total, 2.4 mg of
the mixture of sorangibactins A1 and A2 was obtained and stored under
nitrogen at &#x02212;20 &#x000b0;C until further use. For isolation of
sorangibactin B, the fraction resulted from Biotage work up was treated
with hydrolyzing conditions, followed by the same purification protocol
compared to sorangibactins A1 and A2. Finally, 4.5 mg of sorangibactin
B isomer mixture could be obtained.</p></sec><sec id="sec4.2"><label>4.2</label><title>HPLC-HRMS
Measurements</title><p>All HPLC-HRMS
measurements were conducted on a maXis 4G UHR-TOF system (Bruker Daltonics)
equipped with an ESI source and coupled to a Dionex UltiMate 3000
rapid separation liquid chromatography (RSLC, Thermo Fisher) system.
Separation was achieved with an Acquity BEH C18 column (100 mm &#x000d7;
2.1 mm, 1.7 &#x003bc;m dp) (Waters) in combination with a Waters VanGuard
BEH C18 1.7 &#x003bc;m guard using a linear 5&#x02013;95% gradient of
acetonitrile with 0.1% formic acid in ddH<sub>2</sub>O with 0.1% formic
acid for 18 min. Detection was conducted by a diode array detector
at 200&#x02013;600 nm, the flow rate adjusted to 0.6 mL/min, the column
heated to 45 &#x000b0;C, and the LC flow split to 75 &#x003bc;L/min before
entering the mass spectrometer. Following MS settings were applied
for standard measurements: capillary voltage 4000 V, end plate offset
&#x02212;500 V, nebulizer gas pressure 1 bar, dry gas flow rate 5 L/min,
dry gas temperature 200 &#x000b0;C, and mass scan range <italic>m</italic>/<italic>z</italic> 150&#x02013;2500. MS/MS measurements were carried
out in collision-induced dissociation (CID) fragmentation mode with
a collision energy of 5 eV. The mass spectrometer was calibrated in
quadratic + HPC calibration mode on the masses of the first isotope
signal of sodium formate clusters, which are formed in the ion source
after co-injection of a mixture of 1 mM sodium hydroxide in 1:1 water/isopropanol
+ 0.1% FA. Additional lock mass calibration was performed on <italic>m</italic>/<italic>z</italic> 622.0277, <italic>m</italic>/<italic>z</italic> 922.0103, and <italic>m</italic>/<italic>z</italic> 1221.9960.</p></sec><sec id="sec4.3"><label>4.3</label><title>Marfey&#x02019;s Analysis for the Determination
of Stereochemistry</title><p>For the determination of stereocenters
7 and 12 of the <italic>N</italic>-methylated thiazolidines as well
as stereo center 4 of the cyclic homocysteine thiolactone moiety,
an adapted Marfey&#x02019;s derivatization protocol already described
for the thiamyxins<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> was applied after
acidic hydrolysis to <italic>N</italic>-methyl cysteine and homocysteine,
respectively.</p></sec><sec id="sec4.4"><label>4.4</label><title>NMR Measurements</title><p>For structure elucidation
of sorangibactins A1 and A2, all <sup>1</sup>H-, <sup>13</sup>C-,
and 2D-NMR spectra were acquired in methanol-<italic>d</italic><sub>4</sub> on a Bruker Avance III (Ascend) 700 MHz spectrometer equipped
with a 5 mm TCI cryoprobe using standard pulse programs. Observed
chemical shifts (&#x003b4;) are listed in ppm, coupling constants (<italic>J</italic>) in Hz, and all spectra were calibrated with respective
methanol signals at &#x003b4;(<sup>1</sup>H) = 3.31 ppm and &#x003b4;(<sup>13</sup>C) = 49.2 ppm. Sorangibactin B was measured using the same
parameters on a Bruker Avance III (Ultrashield) 500 MHz spectrometer.</p></sec></sec></body><back><notes id="notes-2" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acschembio.3c00063?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.3c00063</ext-link>.<list id="silist" list-type="simple"><list-item><p>Materials and methods;
gene cluster annotation; scheme
for gene cluster engineering; domain and protein analysis; bioactivity
results; and HPLC-MS and NMR data (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschembio.3c00063/suppl_file/cb3c00063_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb3c00063_si_001.pdf"><caption><p>cb3c00063_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes-1"><title>Author Contributions</title><p><sup>&#x02225;</sup> Y.G. and
C.W. contributed equally to this work.</p></notes><notes notes-type="COI-statement" id="NOTES-d14e955-autogenerated"><p>The authors
declare no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>The authors thank R. Garcia
for providing
the myxobacterial
strain, V. George and A. Amann for bioactivity tests, D. Krug and
N. A. Frank for helpful discussion, and F. Panter for assistance in
metabolome analysis and compound purification. Y.G. acknowledges the
China Scholarship Council for a fellowship of the PhD program. Research
in R.M.&#x02019;s laboratory was partially funded by the Bundesministerium
f&#x000fc;r Bildung und Forschung (BMBF) and Deutsche Forschungsgemeinschaft
(DFG).</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Gerth</surname><given-names>K.</given-names></name>; <name><surname>Pradella</surname><given-names>S.</given-names></name>; <name><surname>Perlova</surname><given-names>O.</given-names></name>; <name><surname>Beyer</surname><given-names>S.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
<article-title>Myxobacteria:
proficient producers of novel natural products with various biological
activities - past and future biotechnological aspects with the focus
on the genus <italic>Sorangium</italic></article-title>. <source>J.
Biotechnol.</source>
<year>2003</year>, <volume>106</volume>, <fpage>233</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2003.07.015</pub-id>.<pub-id pub-id-type="pmid">14651865</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Herrmann</surname><given-names>J.</given-names></name>; <name><surname>Fayad</surname><given-names>A. A.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
<article-title>Natural products
from myxobacteria:
novel metabolites and bioactivities</article-title>. <source>Nat. Prod.
Rep.</source>
<year>2017</year>, <volume>34</volume>, <fpage>135</fpage>&#x02013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1039/c6np00106h</pub-id>.<pub-id pub-id-type="pmid">27907217</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Bauman</surname><given-names>K. D.</given-names></name>; <name><surname>Butler</surname><given-names>K. S.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name>; <name><surname>Chekan</surname><given-names>J. R.</given-names></name>
<article-title>Genome mining methods
to discover bioactive natural products</article-title>. <source>Nat.
Prod. Rep.</source>
<year>2021</year>, <volume>38</volume>, <fpage>2100</fpage>&#x02013;<lpage>2129</lpage>. <pub-id pub-id-type="doi">10.1039/D1NP00032B</pub-id>.<pub-id pub-id-type="pmid">34734626</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Panter</surname><given-names>F.</given-names></name>; <name><surname>Krug</surname><given-names>D.</given-names></name>; <name><surname>Baumann</surname><given-names>S.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
<article-title>Self-resistance
guided genome mining uncovers new topoisomerase inhibitors from myxobacteria</article-title>. <source>Chem. Sci.</source>
<year>2018</year>, <volume>9</volume>, <fpage>4898</fpage>&#x02013;<lpage>4908</lpage>. <pub-id pub-id-type="doi">10.1039/C8SC01325J</pub-id>.<pub-id pub-id-type="pmid">29910943</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Gavriilidou</surname><given-names>A.</given-names></name>; <name><surname>Kautsar</surname><given-names>S. A.</given-names></name>; <name><surname>Zaburannyi</surname><given-names>N.</given-names></name>; <name><surname>Krug</surname><given-names>D.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>; <name><surname>Medema</surname><given-names>M. H.</given-names></name>; <name><surname>Ziemert</surname><given-names>N.</given-names></name>
<article-title>Compendium
of specialized metabolite
biosynthetic diversity encoded in bacterial genomes</article-title>. <source>Nat. Microbiol.</source>
<year>2022</year>, <volume>7</volume>, <fpage>726</fpage>&#x02013;<lpage>735</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-022-01110-2</pub-id>.<pub-id pub-id-type="pmid">35505244</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Huo</surname><given-names>L.</given-names></name>; <name><surname>Hug</surname><given-names>J. J.</given-names></name>; <name><surname>Fu</surname><given-names>C.</given-names></name>; <name><surname>Bian</surname><given-names>X.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
<article-title>Heterologous
expression of bacterial natural product
biosynthetic pathways</article-title>. <source>Nat. Prod. Rep.</source>
<year>2019</year>, <volume>36</volume>, <fpage>1412</fpage>&#x02013;<lpage>1436</lpage>. <pub-id pub-id-type="doi">10.1039/c8np00091c</pub-id>.<pub-id pub-id-type="pmid">30620035</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Clos</surname><given-names>J.</given-names></name>; <name><surname>Zander-Dinse</surname><given-names>D.</given-names></name>
<article-title>Cosmid Library Construction and Functional Cloning</article-title>. <source>Methods Mol. Biol.</source>
<year>2019</year>, <volume>1971</volume>, <fpage>123</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-9210-2_6</pub-id>.<pub-id pub-id-type="pmid">30980301</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Wenzel</surname><given-names>S. C.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
<article-title>Recent developments
towards the heterologous expression
of complex bacterial natural product biosynthetic pathways</article-title>. <source>Curr. Opin. Biotechnol.</source>
<year>2005</year>, <volume>16</volume>, <fpage>594</fpage>&#x02013;<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2005.10.001</pub-id>.<pub-id pub-id-type="pmid">16226455</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Hider</surname><given-names>R. C.</given-names></name>; <name><surname>Kong</surname><given-names>X.</given-names></name>
<article-title>Chemistry and biology
of siderophores</article-title>. <source>Nat.
Prod. Rep.</source>
<year>2010</year>, <volume>27</volume>, <fpage>637</fpage>&#x02013;<lpage>657</lpage>. <pub-id pub-id-type="doi">10.1039/B906679A</pub-id>.<pub-id pub-id-type="pmid">20376388</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Kunze</surname><given-names>B.</given-names></name>; <name><surname>Bedorf</surname><given-names>N.</given-names></name>; <name><surname>Kohl</surname><given-names>W.</given-names></name>; <name><surname>H&#x000f6;fle</surname><given-names>G.</given-names></name>; <name><surname>Reichenbach</surname><given-names>H.</given-names></name>
<article-title>Myxochelin A, a new iron-chelating
compound from <italic>Angiococcus disciformis</italic> (Myxobacterales). Production,
isolation, physico-chemical and biological properties</article-title>. <source>J. Antibiot.</source>
<year>1989</year>, <volume>42</volume>, <fpage>14</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.42.14</pub-id>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Nadmid</surname><given-names>S.</given-names></name>; <name><surname>Plaza</surname><given-names>A.</given-names></name>; <name><surname>Lauro</surname><given-names>G.</given-names></name>; <name><surname>Garcia</surname><given-names>R.</given-names></name>; <name><surname>Bifulco</surname><given-names>G.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
<article-title>Hyalachelins
A-C, unusual siderophores isolated from
the terrestrial myxobacterium <italic>Hyalangium minutum</italic></article-title>. <source>Org. Lett.</source>
<year>2014</year>, <volume>16</volume>, <fpage>4130</fpage>&#x02013;<lpage>4133</lpage>. <pub-id pub-id-type="doi">10.1021/ol501826a</pub-id>.<pub-id pub-id-type="pmid">25058569</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Kunze</surname><given-names>B.</given-names></name>; <name><surname>Trowitzsch-Kienast</surname><given-names>W.</given-names></name>; <name><surname>H&#x000f6;fle</surname><given-names>G.</given-names></name>; <name><surname>Reichenbach</surname><given-names>H.</given-names></name>
<article-title>Nannochelins
A, B and C, new iron-chelating compounds from <italic>Nannocystis
exedens</italic> (myxobacteria). Production, isolation, physico-chemical
and biological properties</article-title>. <source>J. Antibiot.</source>
<year>1992</year>, <volume>45</volume>, <fpage>147</fpage>&#x02013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.45.147</pub-id>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Qiu</surname><given-names>Z.</given-names></name>; <name><surname>Tan</surname><given-names>H.</given-names></name>; <name><surname>Cao</surname><given-names>L.</given-names></name>
<article-title>Siderophore production by actinobacteria</article-title>. <source>BioMetals</source>
<year>2014</year>, <volume>27</volume>, <fpage>623</fpage>&#x02013;<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1007/s10534-014-9739-2</pub-id>.<pub-id pub-id-type="pmid">24770987</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Bentley</surname><given-names>S. D.</given-names></name>; <name><surname>Chater</surname><given-names>K. F.</given-names></name>; <name><surname>Cerde&#x000f1;o-T&#x000e1;rraga</surname><given-names>A.-M.</given-names></name>; <name><surname>Challis</surname><given-names>G. L.</given-names></name>; <name><surname>Thomson</surname><given-names>N. R.</given-names></name>; <name><surname>James</surname><given-names>K. D.</given-names></name>; <name><surname>Harris</surname><given-names>D. E.</given-names></name>; <name><surname>Quail</surname><given-names>M. A.</given-names></name>; <name><surname>Kieser</surname><given-names>H.</given-names></name>; <name><surname>Harper</surname><given-names>D.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name>; <name><surname>Brown</surname><given-names>S.</given-names></name>; <name><surname>Chandra</surname><given-names>G.</given-names></name>; <name><surname>Chen</surname><given-names>C. W.</given-names></name>; <name><surname>Collins</surname><given-names>M.</given-names></name>; <name><surname>Cronin</surname><given-names>A.</given-names></name>; <name><surname>Fraser</surname><given-names>A.</given-names></name>; <name><surname>Goble</surname><given-names>A.</given-names></name>; <name><surname>Hidalgo</surname><given-names>J.</given-names></name>; <name><surname>Hornsby</surname><given-names>T.</given-names></name>; <name><surname>Howarth</surname><given-names>S.</given-names></name>; <name><surname>Huang</surname><given-names>C.-H.</given-names></name>; <name><surname>Kieser</surname><given-names>T.</given-names></name>; <name><surname>Larke</surname><given-names>L.</given-names></name>; <name><surname>Murphy</surname><given-names>L.</given-names></name>; <name><surname>Oliver</surname><given-names>K.</given-names></name>; <name><surname>O&#x02019;Neil</surname><given-names>S.</given-names></name>; <name><surname>Rabbinowitsch</surname><given-names>E.</given-names></name>; <name><surname>Rajandream</surname><given-names>M.-A.</given-names></name>; <name><surname>Rutherford</surname><given-names>K.</given-names></name>; <name><surname>Rutter</surname><given-names>S.</given-names></name>; <name><surname>Seeger</surname><given-names>K.</given-names></name>; <name><surname>Saunders</surname><given-names>D.</given-names></name>; <name><surname>Sharp</surname><given-names>S.</given-names></name>; <name><surname>Squares</surname><given-names>R.</given-names></name>; <name><surname>Squares</surname><given-names>S.</given-names></name>; <name><surname>Taylor</surname><given-names>K.</given-names></name>; <name><surname>Warren</surname><given-names>T.</given-names></name>; <name><surname>Wietzorrek</surname><given-names>A.</given-names></name>; <name><surname>Woodward</surname><given-names>J.</given-names></name>; <name><surname>Barrell</surname><given-names>B. G.</given-names></name>; <name><surname>Parkhill</surname><given-names>J.</given-names></name>; <name><surname>Hopwood</surname><given-names>D. A.</given-names></name>
<article-title>Complete genome sequence of the model actinomycete <italic>Streptomyces coelicolor</italic> A3(2)</article-title>. <source>Nature</source>
<year>2002</year>, <volume>417</volume>, <fpage>141</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1038/417141a</pub-id>.<pub-id pub-id-type="pmid">12000953</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Johnstone</surname><given-names>T. C.</given-names></name>; <name><surname>Nolan</surname><given-names>E. M.</given-names></name>
<article-title>Beyond iron: non-classical
biological functions of
bacterial siderophores</article-title>. <source>Dalton Trans.</source>
<year>2015</year>, <volume>44</volume>, <fpage>6320</fpage>&#x02013;<lpage>6339</lpage>. <pub-id pub-id-type="doi">10.1039/C4DT03559C</pub-id>.<pub-id pub-id-type="pmid">25764171</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Blin</surname><given-names>K.</given-names></name>; <name><surname>Shaw</surname><given-names>S.</given-names></name>; <name><surname>Kloosterman</surname><given-names>A. M.</given-names></name>; <name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name>; <name><surname>van Wezel</surname><given-names>G. P.</given-names></name>; <name><surname>Medema</surname><given-names>M. H.</given-names></name>; <name><surname>Weber</surname><given-names>T.</given-names></name>
<article-title>antiSMASH 6.0: improving
cluster detection and comparison capabilities</article-title>. <source>Nucleic Acids Res.</source>
<year>2021</year>, <volume>49</volume>, <fpage>W29</fpage>&#x02013;<lpage>W35</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab335</pub-id>.<pub-id pub-id-type="pmid">33978755</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Yang</surname><given-names>Y.-J.</given-names></name>; <name><surname>Singh</surname><given-names>R. P.</given-names></name>; <name><surname>Lan</surname><given-names>X.</given-names></name>; <name><surname>Zhang</surname><given-names>C.-S.</given-names></name>; <name><surname>Li</surname><given-names>Y.-Z.</given-names></name>; <name><surname>Li</surname><given-names>Y.-Q.</given-names></name>; <name><surname>Sheng</surname><given-names>D.-H.</given-names></name>
<article-title>Genome
Editing in Model Strain <italic>Myxococcus xanthus</italic> DK1622 by a Site-Specific Cre/loxP
Recombination System</article-title>. <source>Biomolecules</source>
<year>2018</year>, <volume>8</volume>, <elocation-id>137</elocation-id><pub-id pub-id-type="doi">10.3390/biom8040137</pub-id>.<pub-id pub-id-type="pmid">30404219</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Jang</surname><given-names>J.-P.</given-names></name>; <name><surname>Kwon</surname><given-names>M. C.</given-names></name>; <name><surname>Nogawa</surname><given-names>T.</given-names></name>; <name><surname>Takahashi</surname><given-names>S.</given-names></name>; <name><surname>Osada</surname><given-names>H.</given-names></name>; <name><surname>Ahn</surname><given-names>J. S.</given-names></name>; <name><surname>Ko</surname><given-names>S.-K.</given-names></name>; <name><surname>Jang</surname><given-names>J.-H.</given-names></name>
<article-title>Thiolactomide:
A New Homocysteine Thiolactone Derivative from <italic>Streptomyces</italic> sp. with Neuroprotective Activity</article-title>. <source>J. Microbiol.
Biotechnol.</source>
<year>2021</year>, <volume>31</volume>, <fpage>1667</fpage>&#x02013;<lpage>1671</lpage>. <pub-id pub-id-type="doi">10.4014/jmb.2108.08015</pub-id>.<pub-id pub-id-type="pmid">34528916</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Haag</surname><given-names>H.</given-names></name>; <name><surname>Hantke</surname><given-names>K.</given-names></name>; <name><surname>Drechsel</surname><given-names>H.</given-names></name>; <name><surname>Stojiljkovic</surname><given-names>I.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Z&#x000e4;hner</surname><given-names>H.</given-names></name>
<article-title>Purification
of yersiniabactin: a
siderophore and possible virulence factor of <italic>Yersinia
enterocolitica</italic></article-title>. <source>Microbiology</source>
<year>1993</year>, <volume>139</volume>, <fpage>2159</fpage>&#x02013;<lpage>2165</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-139-9-2159</pub-id>.</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Miller</surname><given-names>M. C.</given-names></name>; <name><surname>Parkin</surname><given-names>S.</given-names></name>; <name><surname>Fetherston</surname><given-names>J. D.</given-names></name>; <name><surname>Perry</surname><given-names>R. D.</given-names></name>; <name><surname>DeMoll</surname><given-names>E.</given-names></name>
<article-title>Crystal structure
of ferric-yersiniabactin, a virulence factor of <italic>Yersinia
pestis</italic></article-title>. <source>J. Inorg. Biochem.</source>
<year>2006</year>, <volume>100</volume>, <fpage>1495</fpage>&#x02013;<lpage>1500</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2006.04.007</pub-id>.<pub-id pub-id-type="pmid">16806483</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Fife</surname><given-names>T. H.</given-names></name>; <name><surname>Natarajan</surname><given-names>R.</given-names></name>; <name><surname>Shen</surname><given-names>C. C.</given-names></name>; <name><surname>Bembi</surname><given-names>R.</given-names></name>
<article-title>Mechanism of thiazolidine
hydrolysis. Ring opening and hydrolysis of 1,3-thiazolidine derivatives
of <italic>p</italic>-(dimethylamino)cinnamaldehyde</article-title>. <source>J. Am. Chem. Soc.</source>
<year>1991</year>, <volume>113</volume>, <fpage>3071</fpage>&#x02013;<lpage>3079</lpage>. <pub-id pub-id-type="doi">10.1021/ja00008a041</pub-id>.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Schulz</surname><given-names>M.</given-names></name>; <name><surname>Gaitanoglou</surname><given-names>V.</given-names></name>; <name><surname>Mantel</surname><given-names>O.</given-names></name>; <name><surname>H&#x000f6;velmann</surname><given-names>Y.</given-names></name>; <name><surname>H&#x000fc;bner</surname><given-names>F.</given-names></name>; <name><surname>Dobrindt</surname><given-names>U.</given-names></name>; <name><surname>Humpf</surname><given-names>H.-U.</given-names></name>
<article-title>Metabolomics Study
on Pathogenic and Non-pathogenic <italic>E. coli</italic> with Closely Related Genomes with a Focus on Yersiniabactin and
Its Known and Novel Derivatives</article-title>. <source>Metabolites</source>
<year>2020</year>, <volume>10</volume>, <elocation-id>221</elocation-id><pub-id pub-id-type="doi">10.3390/metabo10060221</pub-id>.<pub-id pub-id-type="pmid">32481767</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Hermenau</surname><given-names>R.</given-names></name>; <name><surname>Mehl</surname><given-names>J. L.</given-names></name>; <name><surname>Ishida</surname><given-names>K.</given-names></name>; <name><surname>Dose</surname><given-names>B.</given-names></name>; <name><surname>Pidot</surname><given-names>S. J.</given-names></name>; <name><surname>Stinear</surname><given-names>T. P.</given-names></name>; <name><surname>Hertweck</surname><given-names>C.</given-names></name>
<article-title>Genomics-Driven Discovery
of NO-Donating
Diazeniumdiolate Siderophores in Diverse Plant-Associated Bacteria</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2019</year>, <volume>58</volume>, <fpage>13024</fpage>&#x02013;<lpage>13029</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201906326</pub-id>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Neilands</surname><given-names>J. B.</given-names></name>
<article-title>Siderophores:
structure and function of microbial iron transport compounds</article-title>. <source>J. Biol. Chem.</source>
<year>1995</year>, <volume>270</volume>, <fpage>26723</fpage>&#x02013;<lpage>26726</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.45.26723</pub-id>.<pub-id pub-id-type="pmid">7592901</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Wilhelm</surname><given-names>S. W.</given-names></name>; <name><surname>Trick</surname><given-names>C. G.</given-names></name>
<article-title>Iron-limited growth of cyanobacteria: Multiple siderophore
production is a common response</article-title>. <source>Limnol. Oceanogr.</source>
<year>1994</year>, <volume>39</volume>, <fpage>1979</fpage>&#x02013;<lpage>1984</lpage>. <pub-id pub-id-type="doi">10.4319/lo.1994.39.8.1979</pub-id>.</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Perry</surname><given-names>R. D.</given-names></name>; <name><surname>Balbo</surname><given-names>P. B.</given-names></name>; <name><surname>Jones</surname><given-names>H. A.</given-names></name>; <name><surname>Fetherston</surname><given-names>J. D.</given-names></name>; <name><surname>DeMoll</surname><given-names>E.</given-names></name>
<article-title>Yersiniabactin from <italic>Yersinia pestis</italic>: biochemical characterization of
the siderophore and its role in
iron transport and regulation</article-title>. <source>Microbiology</source>
<year>1999</year>, <volume>145</volume>, <fpage>1181</fpage>&#x02013;<lpage>1190</lpage>. <pub-id pub-id-type="doi">10.1099/13500872-145-5-1181</pub-id>.<pub-id pub-id-type="pmid">10376834</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Kerbarh</surname><given-names>O.</given-names></name>; <name><surname>Ciulli</surname><given-names>A.</given-names></name>; <name><surname>Howard</surname><given-names>N. I.</given-names></name>; <name><surname>Abell</surname><given-names>C.</given-names></name>
<article-title>Salicylate biosynthesis:
Overexpression, purification, and characterization of Irp9, a bifunctional
salicylate synthase from <italic>Yersinia enterocolitica</italic></article-title>. <source>J. Bacteriol.</source>
<year>2005</year>, <volume>187</volume>, <fpage>5061</fpage>&#x02013;<lpage>5066</lpage>. <pub-id pub-id-type="doi">10.1128/JB.187.15.5061&#x02013;5066.2005</pub-id>.<pub-id pub-id-type="pmid">16030197</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Little</surname><given-names>R. F.</given-names></name>; <name><surname>Hertweck</surname><given-names>C.</given-names></name>
<article-title>Chain release mechanisms
in polyketide and non-ribosomal
peptide biosynthesis</article-title>. <source>Nat. Prod. Rep.</source>
<year>2022</year>, <volume>39</volume>, <fpage>163</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1039/d1np00035g</pub-id>.<pub-id pub-id-type="pmid">34622896</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Thongkongkaew</surname><given-names>T.</given-names></name>; <name><surname>Ding</surname><given-names>W.</given-names></name>; <name><surname>Bratovanov</surname><given-names>E.</given-names></name>; <name><surname>Oueis</surname><given-names>E.</given-names></name>; <name><surname>Garc&#x00131;
A-Altares</surname><given-names>M. A.</given-names></name>; <name><surname>Zaburannyi</surname><given-names>N.</given-names></name>; <name><surname>Harmrolfs</surname><given-names>K.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Scherlach</surname><given-names>K.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>; <name><surname>Hertweck</surname><given-names>C.</given-names></name>
<article-title>Two Types of Threonine-Tagged Lipopeptides Synergize
in Host Colonization by Pathogenic <italic>Burkholderia</italic> Species</article-title>. <source>ACS Chem. Biol.</source>
<year>2018</year>, <volume>13</volume>, <fpage>1370</fpage>&#x02013;<lpage>1379</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.8b00221</pub-id>.<pub-id pub-id-type="pmid">29669203</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Lim</surname><given-names>Y.-R.</given-names></name>; <name><surname>Hong</surname><given-names>M.-K.</given-names></name>; <name><surname>Kim</surname><given-names>J.-K.</given-names></name>; <name><surname>Doan</surname><given-names>T. T. N.</given-names></name>; <name><surname>Kim</surname><given-names>D.-H.</given-names></name>; <name><surname>Yun</surname><given-names>C.-H.</given-names></name>; <name><surname>Chun</surname><given-names>Y.-J.</given-names></name>; <name><surname>Kang</surname><given-names>L.-W.</given-names></name>; <name><surname>Kim</surname><given-names>D.</given-names></name>
<article-title>Crystal structure
of cytochrome P450 CYP105N1 from <italic>Streptomyces coelicolor</italic>, an oxidase in the coelibactin siderophore biosynthetic pathway</article-title>. <source>Arch. Biochem. Biophys</source>
<year>2012</year>, <volume>528</volume>, <fpage>111</fpage>&#x02013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2012.09.001</pub-id>.<pub-id pub-id-type="pmid">23000034</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Zhao</surname><given-names>B.</given-names></name>; <name><surname>Moody</surname><given-names>S. C.</given-names></name>; <name><surname>Hider</surname><given-names>R. C.</given-names></name>; <name><surname>Lei</surname><given-names>L.</given-names></name>; <name><surname>Kelly</surname><given-names>S. L.</given-names></name>; <name><surname>Waterman</surname><given-names>M. R.</given-names></name>; <name><surname>Lamb</surname><given-names>D. C.</given-names></name>
<article-title>Structural analysis
of cytochrome
P450 105N1 involved in the biosynthesis of the zincophore, coelibactin</article-title>. <source>Int. J. Mol. Sci.</source>
<year>2012</year>, <volume>13</volume>, <fpage>8500</fpage>&#x02013;<lpage>8513</lpage>. <pub-id pub-id-type="doi">10.3390/ijms13078500</pub-id>.<pub-id pub-id-type="pmid">22942716</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Meneely</surname><given-names>K. M.</given-names></name>; <name><surname>Lamb</surname><given-names>A. L.</given-names></name>
<article-title>Two structures of a thiazolinyl imine reductase from <italic>Yersinia enterocolitica</italic> provide insight into catalysis
and binding to the nonribosomal peptide synthetase module of HMWP1</article-title>. <source>Biochemistry</source>
<year>2012</year>, <volume>51</volume>, <fpage>9002</fpage>&#x02013;<lpage>9013</lpage>. <pub-id pub-id-type="doi">10.1021/bi3011016</pub-id>.<pub-id pub-id-type="pmid">23066849</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Meneely</surname><given-names>K. M.</given-names></name>; <name><surname>Ronnebaum</surname><given-names>T. A.</given-names></name>; <name><surname>Riley</surname><given-names>A. P.</given-names></name>; <name><surname>Prisinzano</surname><given-names>T. E.</given-names></name>; <name><surname>Lamb</surname><given-names>A. L.</given-names></name>
<article-title>Holo Structure and
Steady State Kinetics of the Thiazolinyl
Imine Reductases for Siderophore Biosynthesis</article-title>. <source>Biochemistry</source>
<year>2016</year>, <volume>55</volume>, <fpage>5423</fpage>&#x02013;<lpage>5433</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biochem.6b00735</pub-id>.<pub-id pub-id-type="pmid">27601130</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>He</surname><given-names>P.</given-names></name>; <name><surname>Moran</surname><given-names>G. R.</given-names></name>
<article-title>Structural and mechanistic
comparisons of the metal-binding
members of the vicinal oxygen chelate (VOC) superfamily</article-title>. <source>J. Inorg. Biochem.</source>
<year>2011</year>, <volume>105</volume>, <fpage>1259</fpage>&#x02013;<lpage>1272</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2011.06.006</pub-id>.<pub-id pub-id-type="pmid">21820381</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Haack</surname><given-names>P. A.</given-names></name>; <name><surname>Harmrolfs</surname><given-names>K.</given-names></name>; <name><surname>Bader</surname><given-names>C. D.</given-names></name>; <name><surname>Garcia</surname><given-names>R.</given-names></name>; <name><surname>Gunesch</surname><given-names>A. P.</given-names></name>; <name><surname>Haid</surname><given-names>S.</given-names></name>; <name><surname>Popoff</surname><given-names>A.</given-names></name>; <name><surname>Voltz</surname><given-names>A.</given-names></name>; <name><surname>Kim</surname><given-names>H.</given-names></name>; <name><surname>Bartenschlager</surname><given-names>R.</given-names></name>; <name><surname>Pietschmann</surname><given-names>T.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
<article-title>Thiamyxins:
Structure and Biosynthesis of Myxobacterial RNA-Virus Inhibitors</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2022</year>, <volume>61</volume>, <elocation-id>e202212946</elocation-id><pub-id pub-id-type="doi">10.1002/anie.202212946</pub-id>.</mixed-citation></ref></ref-list></back></article>